Reuters logo
4 个月前
BRIEF-Glenmark Pharmaceuticals receives FDA clearance of IND for GSP 304
2017年3月7日 / 下午4点22分 / 4 个月前

BRIEF-Glenmark Pharmaceuticals receives FDA clearance of IND for GSP 304

1 分钟阅读

March 7 (Reuters) - Glenmark Pharmaceuticals Ltd:

* Glenmark Pharmaceuticals receives FDA clearance of IND for GSP 304

* Plans to initiate clinical development with a Phase 2 study of GSP 304 in subjects with mild to moderate COPD Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below